3.64000 EUR
0.02
0.55%
Last update Dec 15, 8:13 AM CET
Market closed
Day range
3.64000
3.64000
Previous close
3.66000
Open
3.64000
Access this stock data via API
Subscribe
Nervgen Pharma Corp.
3.64
0.02
0.55%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date 2024
Total reported revenue 0
Cost of revenue
Gross profit
Operating expense
Research & development 9.7M
Selling general and admin 5.7M
Other operating expenses
Operating income -15.4M
Non operating interest income
Income 503.1K
Expense
Other income expense 70.3K
Pretax income -14.9M
Tax provision
Net income -14.9M
Basic EPS -0.4
Diluted EPS -0.4
Basic average shares 41.7M
Diluted average shares 41.7M
EBITDA -15.5M
Net income from continuing op. -14.9M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 34 minutes

07:25
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).